Multifocal Presbyopic Corneal Treatment With the Presbv LASIK (Vejarano Method)

Sunday, April 19, 2015: 8:41 AM
Room 3 (San Diego Convention Center)
Edgar A. Muņoz, MD
L. Felipe Vejarano, MD

To evaluate the predictability, reproducibility, efficacy, reliability, and the stability of this multifocal corneal laser treatment in presbyopic eyes depending of their defect.

Prospective study of the results in pseudoaccommodation, refraction, visual acuity corrected, and uncorrected for far and near distance, residual defect, contrast sensitivity, and stereopsis using the Visx Star S4 IR Custom Vue treatment with central and peripheral ablation profile with the new PresbV (Vejarano Method).

Patients who received presbyopic treatment with Visx Star S4 IR since March 2009 using aberration modulation in the dominant eye and the latest multifocal double ablation profile central and peripheral - PresbV (Vejarano Method) for the non-dominant eye, with this always has very good far and near vision with low percentage of night complains, since the first day and the follow-up goes in some patients until 2 years. Until now with PresbV LASIK 292 eyes of 172 patients in hyperopes, 108 eyes of 58 patients in myopes and 50 emetropes with up to 3 years of follow-up.

This is a promising and less invasive procedure for presbyopia; generating enough independence of glasses for the most activities in the normal life of the patients and could be complemented by the PresbV Tears in both eyes improving accommodation, near vision without altering the far vision.